1. “Associations between PM2.5 and heart rate variability are modified by particle composition and beta-blocker use in patients with coronary heart disease”. de Hartog JJ, Lanki T, Timonen KL, Hoek G, Janssen NAH, Ibald-Mulli A, Peters A, Heinrich J, Tarkainen TH, Van Grieken R, van Wijnen JH, Brunekreef B, Pekkanen J, Environmental health perspectives 117, 105 (2009).   http://doi.org/10.1289/EHP.11062